Editorial: Natural products as drivers in drug development for neurodegenerative disorders
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.8/7583 |
Resumo: | Funding : CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects (UIDB/04292/2020 and UIDP/04292/2020) granted to MARE—Marine and Environmental Sciences Centre, Associate Laboratory ARNET (LA/P/0069/2020), and CROSS-ATLANTIC (PTDC/BIA-OUT/29250/2017), co-financed by European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020). This work was also supported by FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM). |
id |
RCAP_4ea30ec9d16a64ccc8a5e54723ed1299 |
---|---|
oai_identifier_str |
oai:iconline.ipleiria.pt:10400.8/7583 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Editorial: Natural products as drivers in drug development for neurodegenerative disordersNatural products (NP),NeuroinflammationOxidative stressApoptosisMechanisms of actionNeuropharmacologyDrug discoveryEthnopharmacologyFunding : CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects (UIDB/04292/2020 and UIDP/04292/2020) granted to MARE—Marine and Environmental Sciences Centre, Associate Laboratory ARNET (LA/P/0069/2020), and CROSS-ATLANTIC (PTDC/BIA-OUT/29250/2017), co-financed by European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020). This work was also supported by FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM).FrontiersIC-OnlineSilva, JoanaAlvariño, RebecaGoettert, Márcia I.Caruncho, Hector J.Alves, Celso2022-08-23T13:28:49Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.8/7583engSilva J, Alvariño R, Goettert MI, Caruncho HJ and Alves C (2022), Editorial: Natural products as drivers in drug development for neurodegenerative disorders. Front. Pharmacol. 13:932179. doi: 10.3389/fphar.2022.9321791663-981210.3389/fphar.2022.932179info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-17T15:55:31Zoai:iconline.ipleiria.pt:10400.8/7583Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:50:30.930490Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
title |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
spellingShingle |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders Silva, Joana Natural products (NP), Neuroinflammation Oxidative stress Apoptosis Mechanisms of action Neuropharmacology Drug discovery Ethnopharmacology |
title_short |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
title_full |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
title_fullStr |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
title_full_unstemmed |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
title_sort |
Editorial: Natural products as drivers in drug development for neurodegenerative disorders |
author |
Silva, Joana |
author_facet |
Silva, Joana Alvariño, Rebeca Goettert, Márcia I. Caruncho, Hector J. Alves, Celso |
author_role |
author |
author2 |
Alvariño, Rebeca Goettert, Márcia I. Caruncho, Hector J. Alves, Celso |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
IC-Online |
dc.contributor.author.fl_str_mv |
Silva, Joana Alvariño, Rebeca Goettert, Márcia I. Caruncho, Hector J. Alves, Celso |
dc.subject.por.fl_str_mv |
Natural products (NP), Neuroinflammation Oxidative stress Apoptosis Mechanisms of action Neuropharmacology Drug discovery Ethnopharmacology |
topic |
Natural products (NP), Neuroinflammation Oxidative stress Apoptosis Mechanisms of action Neuropharmacology Drug discovery Ethnopharmacology |
description |
Funding : CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects (UIDB/04292/2020 and UIDP/04292/2020) granted to MARE—Marine and Environmental Sciences Centre, Associate Laboratory ARNET (LA/P/0069/2020), and CROSS-ATLANTIC (PTDC/BIA-OUT/29250/2017), co-financed by European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020). This work was also supported by FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM). |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-08-23T13:28:49Z 2022 2022-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.8/7583 |
url |
http://hdl.handle.net/10400.8/7583 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Silva J, Alvariño R, Goettert MI, Caruncho HJ and Alves C (2022), Editorial: Natural products as drivers in drug development for neurodegenerative disorders. Front. Pharmacol. 13:932179. doi: 10.3389/fphar.2022.932179 1663-9812 10.3389/fphar.2022.932179 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers |
publisher.none.fl_str_mv |
Frontiers |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799136997918375936 |